Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02603445 |
| Title | Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | FRA | DEU | AUT |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | New York | New York | 10017 | United States | Details | |
| Novartis Investigative Site | Houston | Texas | 77030 | United States | Details | |
| Novartis Investigative Site | Salzburg | 5020 | Austria | Details | ||
| Novartis Investigative Site | Pierre Benite Cedex | 69495 | France | Details | ||
| Novartis Investigative Site | Toulouse Cedex 9 | 31059 | France | Details | ||
| Novartis Investigative Site | Freiburg | 79106 | Germany | Details | ||
| Novartis Investigative Site | Mainz | 55131 | Germany | Details |